| Issue Date |
Title |
Author(s) |
| Sep-2022 |
Associated factors for discontinuation of statin use one year after discharge in patients with acute coronary syndrome in China |
Xie, Gaoqiang;Myint, Phyo Kyaw;Sun, Yihong;Li, Xian;Wu, Tao;Gao, Run-Lin;Wu, Yangfeng |
| 2009 |
I-LOVE-IT - A Prospective, Multicenter Clinical Trial of TIVOLI Bioabsorbable Polymer Based Sirolimus-Eluting vs. ENDEAVOR Zotarolimus-Eluting Stent in Patients with Coronary Artery Disease: 8-Month Angiographic and 1-Year Clinical Follow-Up Resu |
Xu, Bo;Gao, Run-Lin;Han, Yaling;Lu, Shuzheng;Yang, Yujin;Huo, Yong;Wang, Lefeng;Yang, Tingshu;Wang, Haichang;Chen, Jiyan;Li, Weimin;Wang, Lei;Wang, Yong;Ge, Junbo;Li, Wei |
| 2009 |
Impact of direct sirolimus-eluting stent implantation on the early systemic inflammatory response compared with complementary stent implantation |
Li, Jian-Jun;Zhang, Yu-Ping;Wang, Chun;Gao, Li-Jian;Qin, Xue-Wen;Xu, Bo;Chen, Ji-Lin;Yang, Yue-Jin;Gao, Run-Lin |
| 2012 |
NOYA I: A Prospective Randomized Trial of the Biodegradable Polymer NOYA Sirolimus-Eluting Stent Compared with the Durable Polymer FIREBIRD 2 Sirolimus-Eluting Stent in Patients with Coronary Artery Disease: 9-Month Angiographic and 24-Month Clin |
Xu, Bo;Dou, Kefei;Yang, Yuejin;Lu, Shuzheng;Wang, Lefeng;Wang, Haichang;Li, Zhanquan;Wang, Lei;Chen, YunDai;Huo, Yong;Kirtane, Ajay;Gao, Run-Lin |
| 2016 |
Percutaneous Ventricular Restoration Therapy Using the Parachute Device in Chinese Patients with Ischemic Heart Failure: Three-Month Primary End-point Results of PARACHUTE China Study |
Yang, Yue-Jin;Huo, Yong;Xu, Ya-Wei;Wang, Jian-An;Han, Ya-Ling;Ge, Jun-Bo;Zhang, Rui-Yan;Yan, Xiao-Yan;Gao, Run-Lin |
| 2013 |
A randomised comparison of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: clinical and angiographic follow-up of the TARGET I trial |
Gao, Run-Lin;Xu, Bo;Lansky, Alexandra J.;Yang, Yue-Jin;Ma, Chang-Sheng;Han, Ya-Ling;Chen, Shao-Liang;Li, Hui;Zhang, Rui-Yan;Fu, Guo-Sheng;Yuan, Zu-Yi;Jiang, Hong;Huo, Yong;Li, Wei;Zhang, Yao-Jun;Leon, Martin B. |
| 2017 |
Recombinant human TNK tissue-type plasminogen activator (rhTNK-tPA) versus alteplase (rt-PA) as fibrinolytic therapy for acute ST-segment elevation myocardial infarction (China TNK STEMI): protocol for a randomised, controlled, non-inferiority tr |
Wang, Hai-bo;Ji, Ping;Zhao, Xing-Shan;Xu, Haiyan;Yan, Xiao-Yan;Yang, Qin;Yao, Chen;Gao, Run-Lin;Wu, Yang-feng;Qiao, Shu-Bin |
| 2013 |
Safety and Efficacy of a Novel Abluminal Groove-Filled Biodegradable Polymer Sirolimus-Eluting Stent for the Treatment of De Novo Coronary Lesions: 12-Month Results from the Prospectively Patient-Level Pooled Analysis of the TARGET I and TARGET I |
Gao, Run-Lin;Xu, Bo;Lansky, Alexandra;Yang, Yuejin;Zhang, Ruiyan;Ma Changsheng;Li, Hui;Chen, Shao Liang;Han, Yaling;Yuan, Zuyi;Huo, Yong;Li, Wei;Zhao, Yelin;Leon, Martin |
| 2013 |
Two-Year Clinical Follow-Up of the FIREHAWK Abluminal Groove-Filled Biodegradable Polymer Sirolimus-Eluting Stent in the Treatment of Patients with De Novo Native Coronary Artery Lesions: The TARGET I Trial |
Xu, Bo;Gao, Run-Lin;Lansky, Alexandra;Yang, Yuejin;Ma Changsheng;Han, Yaling;Chen, Shao Liang;Li, Hui;Zhang, Ruiyan;Fu, Guosheng;Yuan, Zuyi;Huo, Yong;Li, Wei;Zhao, Yelin;Leon, Martin |
